These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Current awareness in human psychopharmacology. Hum Psychopharmacol; 2002 Jun; 17(4):201-12. PubMed ID: 12501835 [No Abstract] [Full Text] [Related]
24. Current awareness in human psychopharmacology. Hum Psychopharmacol; 2003 Dec; 18(8):651-62. PubMed ID: 14756132 [No Abstract] [Full Text] [Related]
25. Current awareness in human psychopharmacology. Hum Psychopharmacol; 2004 Jan; 19(1):71-80. PubMed ID: 14964292 [No Abstract] [Full Text] [Related]
26. Why psychopharmacological researchers need to become more vocal and thoughtful in debating issues in research ethics. Young SN J Psychiatry Neurosci; 1998 May; 23(3):147-8. PubMed ID: 9595887 [No Abstract] [Full Text] [Related]
27. Geriatric psychopharmacology: progress in the past decade and directions for the next. Crook T Psychopharmacol Bull; 1983; 19(2):166-7. PubMed ID: 6867233 [No Abstract] [Full Text] [Related]
28. Neurochemistry in the nineties: an overview. Giuffrida Stella AM Neurochem Res; 1987 Feb; 12(2):105-6. PubMed ID: 3574591 [No Abstract] [Full Text] [Related]
29. Basic principles of geriatric psychopharmacology. Granacher RP J Ky Med Assoc; 1981 Jul; 79(7):411-20. PubMed ID: 7264444 [No Abstract] [Full Text] [Related]
30. Behavioral response to pharmacological challenges: potentials and pitfalls. Hollander E Biol Psychiatry; 1995 Jun; 37(12):831-3. PubMed ID: 7548457 [No Abstract] [Full Text] [Related]
31. Effect of psychopharmacological drugs on brain oxidative activity. SIVA SANKAR DV J Neuropsychiatr; 1961; 3():123-5. PubMed ID: 13913510 [No Abstract] [Full Text] [Related]
32. Psychopharmacology in cross-cultural psychiatry. Lin KM Mt Sinai J Med; 1996; 63(5-6):283-4. PubMed ID: 8898528 [No Abstract] [Full Text] [Related]
33. Clinical psychopharmacology: advances and challenges from 1965 to 2006. Crismon ML Ann Pharmacother; 2006 Sep; 40(9):1649-50. PubMed ID: 16896024 [No Abstract] [Full Text] [Related]
34. Introduction: issues and viewpoints in pediatric psychopharmacology. Riddle MA; Walkup JT; Vitiello B Int Rev Psychiatry; 2008 Apr; 20(2):119-20. PubMed ID: 18386200 [No Abstract] [Full Text] [Related]
35. Our continuous interest to promote exchange of views on the most recent developments in the realm of glutamate is manifested by the title of this symposium. Albrecht J; Schousboe A Neurochem Int; 2009; 55(1-3):1. PubMed ID: 19428800 [No Abstract] [Full Text] [Related]
36. Clinical research in the age of neuroscience. Lieberman JA Neuropsychopharmacology; 2000 Jan; 22(1):1-3. PubMed ID: 10633484 [No Abstract] [Full Text] [Related]
38. Recent advances in the psychopharmacology of psychosomatic medicine. Singh AN; Katsuhisa N Seishin Shinkeigaku Zasshi; 2003; 105(4):441-7. PubMed ID: 12806906 [No Abstract] [Full Text] [Related]
39. Psychopharmacology: clinical implications of brain neurochemistry. Scheffer RE Pediatr Clin North Am; 2006 Aug; 53(4):767-75. PubMed ID: 16873004 [TBL] [Abstract][Full Text] [Related]
40. Psychiatric ethics and emerging issues of psychopharmacology in the treatment of depression. Cohan JA J Contemp Health Law Policy; 2003; 20(1):115-72. PubMed ID: 15067929 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]